An Introduction to BLRM
Flexibility of the BLRM in Dose-Escalation Trials
Genpro Research - Finding the right MTD/RP2D for phase 2 is the important goal of phase 1 clinical trials. The popular 3+3 design is being used widely to identify the correct dose,
Flexibility of the BLRM in Dose-Escalation Trials
Bayesian interval dose-finding designs: Methodology and Application
A Bayesian Logistic Model with Covariate to Identify Optimal Dose for Heterogeneous Population in Phase I Oncology Trial Xin Wei, Mike Branson Celgene. - ppt download
Introduction to the new East 6 on the Architect Platform
Tailoring dose escalation designs to early clinical development goals
Flexibility of the BLRM in Dose-Escalation Trials
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial - ScienceDirect
Phase I dose-escalation oncology trials with sequential multiple schedules | BMC Medical Research Methodology | Full Text
Using mixture priors for robust inference: application in Bayesian dose escalation trials
Bayesian designs in clinical trials | Data science, biostatistics, data transparency, bioinformatics and statistical programming
Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era - ScienceDirect
A Bayesian Logistic Model with Covariate to Identify Optimal Dose for Heterogeneous Population in Phase I Oncology Trial Xin Wei, Mike Branson Celgene. - ppt download
Clinical Development
A Competitive Alternative to Model-based Dose Escalation Procedures - YouTube
Introduction to the new East 6 on the Architect Platform
Improving the performance of Bayesian logistic regression model with overdose control in oncology dose‐finding studies - Zhang - 2022 - Statistics in Medicine - Wiley Online Library
5 Reasons to Invest in Bayesian Dose-Escalation Methods
Phase I dose-escalation trials with more than one dosing regimen | DeepAI
A Bayesian Logistic Model with Covariate to Identify Optimal Dose for Heterogeneous Population in Phase I Oncology Trial Xin Wei, Mike Branson Celgene. - ppt download
Using mixture priors for robust inference: application in Bayesian dose escalation trials
